FDA Inspection 936980 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 3002617771

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on Jul 24, 2015 in Frederick, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 24, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Frederick, MD (United States)